Sensory and motor physiological functions are impaired in gastric inhibitory polypeptide receptor-deficient mice

Journal of Diabetes Investigation

Volumn 5, Issue 1, 2014, Pages 31-37

  Okawa, Tetsuji ^a   Kamiya, Hideki ^a   Himeno, Tatsuhito ^a   Seino, Yusuke ^b   Tsunekawa, Shin ^a   Hayashi, Yoshitaka ^c   Harada, Norio ^d   Yamada, Yuichiro ^e   Inagaki, Nobuya ^d   Seino, Yutaka ^f   Oiso, Yutaka ^a   Nakamura, Jiro ^a,g  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NAGOYA UNIVERSITY   (Japan)

^d KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f KANSAI ELECTRIC POWER CO   (Japan)

^g AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Gastric inhibitory polypeptide; Incretins; Peripheral nervous system

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR; RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CURRENT PERCEPTION THRESHOLD; EXPERIMENTAL TEST; GASTRIC INHIBITORY POLYPEPTIDE SIGNALING; IMMUNOHISTOCHEMISTRY; MALE; MOTOR NERVE CONDUCTION; MOUSE; MOUSE STRAIN; NERVE CELL CULTURE; NERVE FIBER GROWTH; NEURITE; NEUROLOGIC DISEASE; NONHUMAN; ORGAN BLOOD FLOW; PERIPHERAL NERVOUS SYSTEM FUNCTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCIATIC NERVE BLOOD FLOW; SENSORY NERVE CONDUCTION; SIGNAL TRANSDUCTION; SKIN BLOOD FLOW; SPINAL GANGLION; THERMAL PLANTAR TEST; WESTERN BLOTTING; WILD TYPE;

EID: 84896707235     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/jdi.12129     Document Type: Article

References (30)

1. Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology 2007; 132: 2131-2157.
2. Inagaki N, Atsumi Y, Oura T, et al. Efficacy and safety profile of exenatide once weekly compared with insulin once daily in Japanese patients with type 2 diabetes treated with oral antidiabetes drug(s): results from a 26-week, randomized, open-label, parallel-group, multicenter. noninferiority study. Clin Ther 2012; 34: 1892-1908.
3. Kubota A, Maeda H, Kanamori A, et al. Efficacy and safety of sitagliptin monotherapy and combination therapy in Japanese type2 diabetes patients. J Diabetes Invest 2012; 3: 503-509.
4. Karagiannis T, Paschos P, Paletas K, et al. Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis. BMJ 2012; 344: e1369.
5. Meier JJ, Nauck MA. Is the diminished incretin effect in type 2 diabetes just an epi-phenomenon of impaired beta-cell function? Diabetes 2010; 59: 1117-1125.
6. Widenmaier SB, Kim SJ, Yang GK, et al. A GIP receptor agonist exhibits beta-cell anti-apoptotic actions in rat models of diabetes resulting in improved beta-cell function and glycemic control. PLoS ONE 2010; 5: e9590.
7. Yabe D, Seino Y. GIP and GLP-1, the two incretin hormones: similarities and differences. J Diabetes Invest 2010; 1: 8-23.
8. Miyawaki K, Yamada Y, Ban N, et al. Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med 2002; 8: 738-742.
9. Tsukiyama K, Yamada Y, Yamada C, et al. Gastric inhibitory polypeptide as an endogenous factor promoting new bone formation after food ingestion. Mol Endocrinol 2006; 20: 1644-1651.
10. Ogawa E, Hosokawa M, Harada N, et al. The effect of gastric inhibitory polypeptide on intestinal glucose absorption and intestinal motility in mice. Biochem Biophys Res Commun 2011; 404: 115-120.
11. Gault VA, Holscher C. Protease-resistant glucose-dependent insulinotropic polypeptide agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid. J Neurophysiol 2008; 99: 1590-1595.
12. Nyberg J, Anderson MF, Meister B, et al. Glucose-dependent insulinotropic polypeptide is expressed in adult hippocampus and induces progenitor cell proliferation. J Neurosci 2005; 25: 1816-1825.
13. Nyberg J, Jacobsson C, Anderson MF, et al. Immunohistochemical distribution of glucose-dependent insulinotropic polypeptide in the adult rat brain. J Neurosci Res 2007; 85: 2099-2119.
14. Hamann C, Kirschner S, Gunther KP, et al. Bone, sweet bone-osteoporotic fractures in diabetes mellitus. Nat Rev Endocrinol 2012; 8: 297-305.
15. McCrimmon RJ, Ryan CM, Frier BM. Diabetes and cognitive dysfunction. Lancet 2012; 379: 2291-2299.
16. Pavelock KA, Girard BM, Schutz KC, et al. Bone morphogenetic protein down-regulation of neuronal pituitary adenylate cyclase-activating polypeptide and reciprocal effects on vasoactive intestinal peptide expression. J Neurochem 2007; 100: 603-616.
17. Martin B. Lopez de Maturana R, Brenneman R, et al. Class II G protein-coupled receptors and their ligands in neuronal function and protection. Neuromolecular Med 2005; 7: 3-36.
18. During MJ, Cao L, Zuzga DS, et al. Glucagon-like peptide-1 receptor is involved in learning and neuroprotection. Nat Med 2003; 9: 1173-1179.
19. Bertilsson G, Patrone C, Zachrisson O, et al. Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease. J Neurosci Res 2008; 86: 326-338.
20. Himeno T, Kamiya H, Naruse K, et al. Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice. Diabetes 2011; 60: 2397-2406.
21. Jolivalt CG, Fineman M, Deacon CF, et al. GLP-1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic mice. Diabetes Obes Metab 2011; 13: 990-1000.
22. Kan M, Guo G, Singh B, et al. Glucagon-like peptide 1, insulin, sensory neurons, and diabetic neuropathy. J Neuropathol Exp Neurol 2012; 71: 494-510.
23. Buhren BA, Gasis M, Thorens B, et al. Glucose-dependent insulinotropic polypeptide (GIP) and its receptor (GIPR): cellular localization, lesion-affected expression, and impaired regenerative axonal growth. J Neurosci Res 2009; 87: 1858-1870.
24. Jin H, Liu W, Park J, et al. Effect of dipeptidyl peptidase-IV (DPP-IV) inhibitor (Vildagliptin) on peripheral nerves in streptozotocin-induced diabetic rats. Arch Med Res 2009; 40: 536-544.
25. De Meester I, Durinx C, Bal G, et al. Natural substrates of dipeptidyl peptidase IV. Adv Exp Med Biol 2000; 477: 67-87.
26. Tosaki T, Kamiya H, Yasuda Y, et al. Reduced NGF secretion by Schwann cells under the high glucose condition decreases neurite outgrowth of DRG neurons. Exp Neurol 2008; 213: 381-387.
27. Nakae M, Kamiya H, Naruse K, et al. Effects of basic fibroblast growth factor on experimental diabetic neuropathy in rats. Diabetes 2006; 55: 1470-1477.
28. Shibata T, Naruse K, Kamiya H, et al. Transplantation of bone marrow-derived mesenchymal stem cells improves diabetic polyneuropathy in rats. Diabetes 2008; 57: 3099-3107.
29. Koga K, Furue H, Rashid M, et al. Selective activation of primary afferent fibers evaluated by sine-wave electrical stimulation. Mol Pain 2005; 1: 13.
30. Veves A, Young MJ, Manes C, et al. Differences in peripheral and autonomic nerve function measurements in painful and painless neuropathy. A clinical study. Diabetes Care 1994; 17: 1200-1202.